Peter Sayre, PhD, MD

Hematologist

Dr. Peter Sayre specializes in adult bone marrow transplantation, hematology and treatment of leukemia, multiple myeloma, lymphoma and Hodgkin's disease. His research interests focus on allogeneic stem cell transplants and leukemia in older adults. His work on these subjects has been widely published in medical and scientific journals. In addition, Sayre is a professor of medicine and director of clinical research at UCSF.

Sayre graduated magna cum laude with an undergraduate degree in philosophy from Yale College. He earned a medical degree at the Robert Wood Johnson Medical School of the University of Medicine and Dentistry of New Jersey as well as a doctorate in immunology at Harvard University. He completed a hematology-oncology fellowship at the University of California, San Francisco before joining the faculty in 1996.

Clinics

Hematology and Blood and Marrow Transplant
400 Parnassus Ave., Fourth Floor
San Francisco, CA 94143
Existing Patients: (415) 353-2421
New Patients: (415) 353-2051
Fax: (415) 353-2467

Hours: Monday to Friday, 8 a.m. - 5 p.m

Conditions & Treatments

Academic Title

Professor

More about Peter Sayre

Additional Languages

French
Spanish

Education

Robert Wood Johnson Medical School 1990

Residencies

UC San Diego, Internal Medicine 1993

Fellowships

UCSF, Oncology 1996
UCSF, Hematology 1996

Selected Research and Publications

  1. du Toit G, Sayre PH, Roberts G, Lawson K, Sever ML, Bahnson HT, Fisher HR, Feeney M, Radulovic S, Basting M, Plaut M, Lack G. Allergen specificity of early peanut consumption and effect on development of allergic disease in the Learning Early About Peanut Allergy study cohort. J Allergy Clin Immunol. 2018 Apr; 141(4):1343-1353.
  2. Nash RA, Hutton GJ, Racke MK, Popat U, Devine SM, Steinmiller KC, Griffith LM, Muraro PA, Openshaw H, Sayre PH, Stuve O, Arnold DL, Wener MH, Georges GE, Wundes A, Kraft GH, Bowen JD. High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS. Neurology. 2017 Feb 28; 88(9):842-852.
  3. Shaked A, Chang BL, Barnes MR, Sayre P, Li YR, Asare S, DesMarais M, Holmes MV, Guettouche T, Keating BJ. An ectopically expressed serum miRNA signature is prognostic, diagnostic, and biologically related to liver allograft rejection. Hepatology. 2017 01; 65(1):269-280.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.